Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-14T04:25:10.877Z Has data issue: false hasContentIssue false
  • English
  • Français

Trends in Rates of Herpes Zoster–Related Hospitalizations Are They Real, Are They Costly, and Are They Linked to Varicella Vaccination?

Published online by Cambridge University Press:  02 January 2015

Rafael Harpaz  and
Barbara P. Yawn
Rafael Harpaz*
Affiliation:
Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Barbara P. Yawn
Affiliation:
Department of Research, Olmsted Medical Center, Rochester, Minnesota
*
Centers for Disease Control and Prevention, Mail Stop A-47, 1600 Clifton Road, Atlanta, GA 30333) RHarpaz@cdc.gov)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 5 , May 2009 , pp. 495 - 496
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

References

1.Patel, MS, Gebremariam, A, Davis, MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol 2008;29:1157–1163.CrossRefGoogle ScholarPubMed
2.Jackson, LA, Reynolds, MA, Harpaz, R. Hospitalizations to treat herpes zoster in older adults: causes and validated rates. Clin Infect Dis 2008;47:754–759.CrossRefGoogle ScholarPubMed
3.Yawn, BP, Saddier, S, Wollan, P, Sauver, JS, Kurland, M, Sy, L. A population-based study of the incidence and complications of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341–1349.CrossRefGoogle ScholarPubMed
4.Lin, F, Hadler, JL. Epidemiology of primary varicella and herpes zoster hospitalizations: the prevaricella vaccine era. J Infect Dis 2000;181:1897–1905.Google Scholar
5.Brisson, M, Gay, NJ, Edmunds, WJ, Andrews, NJ. Exposure to varicella boosts immunity to herpes zoster: implications for mass vaccination against chickenpox. Vaccine 2002;20:2500–2507.Google Scholar
6.Jumaan, A, Yu, O, Jackson, L, Bohlke, K, Galil, K, Seward, J. Incidence of herpes zoster, before and after varicella vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005;191:2002–2007.Google Scholar
7.Mullooly, JP, Riedlinger, K, Chun, C, Weinmann, S, Houston, H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005;133:245–253.Google Scholar
8.Yih, WK, Brooks, DR, Lett, SM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005;5:68.Google Scholar
9.Ragozzino, MW, Melton, LJ 3rd, Kurland, LT, Chu, CP, Perry, HO. Population-based study of herpes zoster and its sequelae. Medicine 1982;61:310–316.Google Scholar
10.Perez-Farinos, N, Ordobas, M, Garcia-Fernandez, C, et al. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004. BMC Infect Dis 2007;7:59.CrossRefGoogle ScholarPubMed
11.Russell, ML, Schopflocher, DP, Svenson, L, Virani, SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 2007;135:908–913.Google Scholar